0001667699-16-000005.txt : 20160502 0001667699-16-000005.hdr.sgml : 20160502 20160502151223 ACCESSION NUMBER: 0001667699-16-000005 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160502 DATE AS OF CHANGE: 20160502 EFFECTIVENESS DATE: 20160502 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Renibus Therapeutics, Inc. CENTRAL INDEX KEY: 0001667699 IRS NUMBER: 810872431 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-258033 FILM NUMBER: 161611390 BUSINESS ADDRESS: STREET 1: 727 LATHROP STREET CITY: LANTANA STATE: TX ZIP: 76226 BUSINESS PHONE: 469-688-3174 MAIL ADDRESS: STREET 1: 727 LATHROP STREET CITY: LANTANA STATE: TX ZIP: 76226 D/A 1 primary_doc.xml X0707 D/A LIVE 0001667699 Renibus Therapeutics, Inc. 727 LATHROP STREET LANTANA TX TEXAS 76226 469-688-3174 DELAWARE None None Corporation true 2015 Harpreet Kaur 727 Lathrop Street Lantana TX TEXAS 76226 Executive Officer Director Chairman of the Board, Chief Executive Officer and President Carlos Guillem 727 Lathrop Street Lantana TX TEXAS 76226 Executive Officer Director Secretary Dale Jones 727 Lathrop Street Lantana TX TEXAS 76226 Director Jennifer D. Rasmussen 727 Lathrop Street Lantana TX TEXAS 76226 Director Jocelyn Keyser 727 Lathrop Street Lantana TX TEXAS 76226 Director Nels Bergmark 727 Lathrop Street Lantana TX TEXAS 76226 Executive Officer Treasurer Pharmaceuticals Decline to Disclose 06b true 0001667699-16-000004 2016-02-10 false true false 0 12500000 10919000 1581000 false 112 0 0 0 false Renibus Therapeutics, Inc. /s/ Harpreet Kaur Harpreet Kaur Chairman of the Board, CEO and President 2016-05-02